➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

GONAL-F RFF Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: GONAL-F RFF

Patents:	5
Applicants:	1
BLAs:	2
Suppliers: see list	1

Patent Text Search: US Patents for GONAL-F RFF

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Emd Serono	GONAL-F RFF	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021765	002	2004-03-25	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	DISCN		search
Emd Serono	GONAL-F RFF	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021765	002	2004-03-25	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	DISCN		search
Emd Serono	GONAL-F RFF	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021765	002	2004-03-25	Start Trial	Amylin Pharmaceuticals, Inc. (San Diego, CA)	2022-01-22	DISCN		search
Emd Serono	GONAL-F RFF	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021765	002	2004-03-25	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	DISCN		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for GONAL-F RFF

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2004052390	Start Trial
Canada	2473927	Start Trial
World Intellectual Property Organization (WIPO)	03061362	Start Trial
Spain	2372481	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Medtronic

Merck

Baxter

Mallinckrodt

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.